Drugs / Tedivax-Adult™
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT01262924 Comparator | Oct 1997 → Dec 1998 | — | GlaxoSmithKline | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Tedivax-Adult | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01262924 ↗ |
| Known as | Td-Rix | “Tedivax-Adult™/ Td-Rix™” NCT01262924 ↗ |
| Route | Intramuscular | “Intramuscular, single dose or 2 doses (in the annex phase)” NCT01262924 ↗ |